VedAryo

VedAryo contains the active substance ‘vedolizumab’. Vedolizumab is a humanized  IgG1 monoclonal antibody that binds to human integrin α4β7 and it produced in Chinese hamster ovary (CHO) cells by recombinant DNA technology.

 

 

OUR GROUP
OUR GROUP
Relying on the technical knowledge and skills of young professionals, Aryogen Pharmed Company intends to invest more in its research and development projects every year, in order to facilitate access to more life-giving drugs. Providing better services in the field of health, Cinnagen Pharmaceutical Group consists of 5 subsidiary companies with Cinnagen as the parent company, includes the following companies.

ARYOGEN GLOBAL FOOTPRINTS